BRIGHTSURF

Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial

01.10.25 | Mundo Sano España

Video animation explains the importance of the results of this phase II/III clinical trial in advacing a novel drug that can help achieve the control goals set by WHO's 2021-2030 Roadmap for the intestinal parasites known as soil-transmitted helminths (STH) Credit: STOP2030.org

The Lancet Infectious Diseases

10.1016/S1473-3099(24)00669-8

Randomized controlled/clinical trial

People

Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial

10-Jan-2025

Jaime Algorta is employee of Laboratorios Liconsa. All other authors declare no competing interests

Keywords

Drug Combinations Medical Parasitology

Article Information

Journal

The Lancet Infectious Diseases

DOI

10.1016/S1473-3099(24)00669-8

Method of Research

Randomized controlled/clinical trial

Subject of Research

People

Article Publication Date

2025-01-10

Article Title

Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial

COI Statement

Jaime Algorta is employee of Laboratorios Liconsa. All other authors declare no competing interests

Contact Information

Borja Robert

Mundo Sano España

borja.robert@mundosano.org

Source

This article is based on a news release from Mundo Sano España. BrightSurf curates and republishes science news from research institutions worldwide; the original release is linked below.

Original Source

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00669-8/fulltext

How to Cite This Article

APA:

Mundo Sano España. (2025, January 10). Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial. Brightsurf News. https://www.brightsurf.com/news/LRDPO6G8/innovative-treatment-for-parasites-affecting-15-billion-people-shows-safety-and-superior-efficacy-in-phase-ii-iii-trial.html

MLA:

"Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial." Brightsurf News, Jan. 10 2025, https://www.brightsurf.com/news/LRDPO6G8/innovative-treatment-for-parasites-affecting-15-billion-people-shows-safety-and-superior-efficacy-in-phase-ii-iii-trial.html.